Did treatment of opioid use disorder (OUD) among Medicaid enrollees change from 2014 to 2018? – HEOR insights

A recent study published in the JAMA aims to understand the use of medications for OUD and potential indicators of quality of care in multiple US states. The research was conducted by ​​The Medicaid Outcomes Distributed Research Network (MODRN) led by Dr. Julie Donohue, Ph.D., chair and professor of the University of Pittsburgh Graduate School of Public Health Department of Health Policy and Management.

The data was obtained and de-identified from 11 states (Delaware, Kentucky, Maryland, Maine, Michigan, North Carolina, Ohio, Pennsylvania, Virginia, West Virginia, and Wisconsin; including the five states that rank among the highest for opioid overdose deaths).

The study found that 

In 2018, prevalence of OUD in these 11 states increased from 3.3% in 2014 to 5.0%“Non-Hispanic Black enrollees had lower OUD medication use than White enrollees (prevalence ratio [PR], 0.72; 95% CI, 0.64 to 0.81; P < .001; 90% prediction interval, 0.52 to 1.00)”Pregnant women had higher use of OUD medications and medication continuity than other eligibility groupsThe variability across states in the quality measures of behavioral health counseling, urine testing and controlled substance prescribing varied greatly

One of the major limitations of the study is that the research may have  underestimated or overestimated opioid use disorder diagnoses due to limited sensitivity and specificity of the OUD diagnosis codes in Medicaid claims data. Nonetheless, the study provides critical insights on the trends in the treatment of opioid use disorder among medicaid enrollees to improve access to quality of care for OUD. 

Source

The Medicaid Outcomes Distributed Research Network (MODRN). Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018. JAMA. 2021;326(2):154–164. doi:10.1001/jama.2021.7374

spot_img

Explore more

Stop Letting Others Control Your Life

Stop Letting Others Control Your Life

SUMMARY: In this episode, Brendon teaches… How to focus more on positive life outcomes like life satisfaction, fitness, happiness, and confidence is essential. Why better embracing significant...

You Asked: In a Woman with ADHD, Should You Continue Treatment...

Question: I have a 32-year-old patient with ADHD who stopped her stimulant medication (Concerta 54 mg) during pregnancy. She is now at 34 weeks of...

The Future of Period Pain Relief

Hey there, womanhood warriors! We get you, and we especially get you on those days of the month. Period cramps are a real problem...
Preventive Care: How It Can Save Your Business Money On Health Insurance

Preventive Care: How It Can Save Your Business Money On Health...

As a small business owner in California or Arizona, you already understand the importance of keeping your employees healthy and productive. But you also...

Biosensor technology company Allez Health secures $60M

California-based Allez Health, formerly Zense-Life, announced it secured $60 million in Series A+ financing.  The round was led by strategic investor Osang Healthcare, with participation...
Omega-3 index test

Omega-3 index test and benefits for overall health and well-being

The Omega-3 Index test...
Thousands of NÜTRL tumblers recalled after dozens report illness - National

Thousands of NÜTRL tumblers recalled after dozens report illness – National

A promotional NÜTRL branded tumbler that was recalled in Canada earlier this month caused multiple reports of adverse health effects, an updated notice said...
Dentistry procurement platforms and trends 2024

E-Procurement Platforms, AI, and More Trends from DentalForum 2024

This article was written by the Planet DDS staff and originally published on DrBicuspid.com.At this year’s DentalForum, leaders from more than two dozen dental...